Common Equity: The sum of all common equity items.
OKYO Pharma Limited Sponsored ADR (OKYO) had Common Equity of $-7.23M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.83M |
|
$0.00M |
|
$0.00M |
|
$2.83M |
|
$10.05M |
|
-- |
|
-- |
|
$10.05M |
|
|
Common Equity |
$-7.23M |
$-7.23M |
|
$-7.23M |
|
33.94M |
|
| Cash Flow Statement Financials | |
$-0.24M |
|
-- |
|
$0.55M |
|
$0.83M |
|
$0.99M |
|
$0.16M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|